Work

Integrating the 31-gene expression profile test into clinical decision-making to guide risk-aligned care decisions for patients with stage I-III cutaneous melanoma: NCI-SEER Analysis.

Year: 2023

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2023.41.16_suppl.6601

Authors: David Hyams, Valentina I. Petkov, Jung S. Byun, Brian Martin, Christine N. Bailey, Brian Gastman

Institutions: National Cancer Institute, National Institutes of Health, Castle Biosciences, Inc. (United States), Cleveland Clinic

Language: English

Topic: Cutaneous Melanoma Detection and Management

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4379335189

Cites:

Cited by:

Related to: 10